Outperform your competition

Curtis Sprouse brings more than 20 of experience in the high-tech, healthcare, pharmaceutical and finance to his position as President at EurekaConnect, LLC. As a founder of Boston Market Strategies, Inc. (www.BMSI3.com), Curt has worked with over 150 organizations including many Fortune 500 companies across many sectors. Curt has advised on business development, sales, marketing and clinical strategy. Prior to founding EurekaConnect Curt served as Director of Special Projects for Mertech. He also served as Chief Financial Officer for OnDuty and Staff Support before assuming the role of President. Curt started his career as staff auditor at Ernst & Young (then Whinney). Curt Studied Business and Accounting at Westminster College in Wilmington, Pennsylvania where he also played four years of football. In his spare time Curt enjoys riding his motorcycle and most importantly spending time with his three kids and wife in the North Shore town of Ipswich.

Kyla Slen brings over 10 years of experience in both the operational and finance areas of business to EurekaConnect having worked in various roles at Reed Business Information. Kyla began her professional career in corporate finance working within the real estate, financial planning & analysis, reporting and strategic planning areas where she developed her expertise in integrating systems and process improvement resulting in smooth work flow between the field and corporate financial community. During her tenure at RBI, Kyla partnered with key stake holders throughout the company on various projects. Kyla is a graduate of Miami University’s Richard T. Farmer School of Business focusing on Finance and Statistics. In addition to her busy work schedule, Kyla enjoys keeping active and healthy participating in running and bicycling events for charities in various parts of the country.

Kara Cleveland has more than 17 years of experience in global healthcare, research and development, and informatics. Kara has spent time consulting and developing in-licensing collaborations within the biotechnology industry. Prior to this, Kara held the position of COO for Campath, as the Director of Program Management at Genzyme, during their acquisition of Ilex Oncology. Kara directed both oncology and non-oncology product business plan development, and served as the co-chair of the Collaborative Global Product Team with Schering AG. Over the course of Kara's career, she has gained experience at all levels of clinical development and change management along with extensive skills in international business development and global team management. Kara is a graduate from the MIT Sloan School of Management, and has a BS in Nursing from the University of Kansas.